Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.
View Top Employees from Axsome Therapeutics, Inc.Website | http://axsome.com |
Ticker | AXSM |
Revenue | $5 million |
Funding | $80.5 million |
Employees | 535 (428 on RocketReach) |
Founded | 2012 |
Address | One World Trade Center, 22nd Floor, New York, New York 10007, US |
Phone | (212) 332-3241 |
Fax | (212) 320-0245 |
Technologies |
JavaScript,
HTML,
Twitter
+15 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Drug Manufacturing & Research, Biopharma, Biopharmaceuticals, Pharmaceuticals, Other Healthcare Services, Pain, Healthcare, Health Care, CNS, Science and Engineering, Therapeutics |
Web Rank | 4 Million |
Keywords | Axsome Therapeutics, Axsm, Axs-05, Axs 05, Axsome Therapeutics Pipeline |
Competitors | Abivax, GenSight Biologics, ONL Therapeutics, Relmada Therapeutics, Inc, Spruce Biosciences |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Axsome Therapeutics, Inc. employee's phone or email?
The Axsome Therapeutics, Inc. annual revenue was $5 million in 2024.
Nick Pizzie is the CFO of Axsome Therapeutics, Inc..
428 people are employed at Axsome Therapeutics, Inc..
Axsome Therapeutics, Inc. is based in New York, New York.
The NAICS codes for Axsome Therapeutics, Inc. are [32541, 3254, 325, 32].
The SIC codes for Axsome Therapeutics, Inc. are [283, 28].